Shares of Surgalign Holdings SRGA moved higher by 0.9% in pre-market trading after the company reported Q2 results.
Quarterly Results
Earnings per share were up 71.88% over the past year to ($0.09), which beat the estimate of ($0.12).
Revenue of $24,834,000 decreased by 54.20% year over year, which beat the estimate of $24,800,000.
Looking Ahead
The upcoming fiscal year's revenue expected to be between $95,000,000 and $100,000,000.
Conference Call Details
Date: Aug 06, 2021
Time: 09:00 AM
ET Webcast URL: https://78449.themediaframe.com/dataconf/productusers/srga/mediaframe/45848/indexl.html
Technicals
Company's 52-week high was at $3.27
Company's 52-week low was at $1.05
Price action over last quarter: down 37.71%
Company Overview
Surgalign Holdings Inc is a medical technology company advancing the science of spine care, focused on delivering innovative solutions that drive superior clinical and economic outcomes. The company continues to invest in clinically validated innovation to deliver better surgical outcomes and improve patient's lives. It markets products throughout the United States and in more than 50 countries worldwide through an expanding network of top independent distributors. The U.S. market accounts for the vast majority of revenue. It has commercial and design centers in San Diego, California, and Wurmlingen, Germany.
© 2024 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.